Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Mike Snape
Person

Mike Snape

Tracked across 1 events · 6 articles · First seen Jul 06, 2026 · Last active Jul 06, 2026

Sentiment
10
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 10
Regulatory
AMO Pharma AMO-02 cDM1 trial design
Impact: As CEO of AMO Pharma, Dr. Snape announced the regulatory agreement and expressed optimism about the study's progress.
Jul 06, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Mike Snape live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.